FDA Drug Application (019129) for MAXZIDE-25 by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number019129
Product Number003
FormTABLET;ORAL
Dosage25MG;37.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMAXZIDE-25
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE



Back to FDA Applications sponsored by MYLAN PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.